GLP-1 receptor agonists are a class of FDA-approved medications that mimic this hormone, producing three powerful effects: Appetite suppression signals your brain that youre full sooner and for longer Slowed gastric emptying food moves through your stomach more slowly, reducing hunger spikes Blood sugar regulation stimulates insulin release in response to meals, supporting metabolic health Originally developed for type 2 diabetes management, GLP-1 medications have since been FDA-approved specifically for chronic weight management in adults with obesity or overweight and related health conditions
Address any behavioral patterns (stress eating, poor sleep, alcohol) that intensified after medication changes
Normal-looking skin can often use a balanced formula
In some cases, your doctor may suggest pausing the use of tirzepatide until after breastfeeding is complete or exploring alternative treatments
Insurance coverage considerations are important, as tirzepatide can be costly, and coverage policies vary regarding approval for OSA, weight management, or diabetes indications